Bereits seit vielen Jahren stellen sich die Mitglieder des Evin Hub gemeinsam komplexen Forschungsfragen. Im Bereich Real-World Evidence können wir einen fundierten wissenschaftlichen Track Record zu verschiedenen Indikationen und Therapiefeldern vorweisen. Dieser belegt, dass wir nicht nur erfolgreich Forschung betreiben, sondern auch ein vertrauensvoller Ansprechpartner für viele namhafte Auftraggeber sind.
Real-World Use of Carfilzomib for the Treatment of Relapsed/Refractory Multiple Myeloma in Germany: Once-Weekly and Twice-Weekly Administration Schedules. Blood 144(Supplement 1):7826-7826. https://doi.org/10.1182/blood-2024-198394
Therapy areas: Oncology/Hematology
Indications: Multiple Myeloma
Patient and Treatment Characteristics of New Users of SGLT-2i and/or ARNi in HFrEF Patients With and Without T2DM: A Real-World Data Analysis Based on German Claims Data. Value in Health 2024, Volume 27, Issue 12, Supplement. https://doi.org/10.1016/j.jval.2024.10.1714
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: HFrEF
Improving Access to German Health Claims Data Through Synthetic Data Generation: A Methodological Comparison of Different Approaches. Value in Health 2024, Volume 27, Issue 12, Supplement. https://doi.org/10.1016/j.jval.2024.10.3753
Therapy areas: General Health
Indications: General
Epidemiologic Findings of Locally Advanced Squamous Cell Carcinoma of the Head and Neck (LA-SCCHN) in a German Liquid Biopsy Database: A Feasibility Analysis. Value in Health 2024, Volume 27, Issue 12, Supplement. https://doi.org/10.1016/j.jval.2024.10.3593
Therapy areas: Oncology/Hematology
Indications: Head and Neck Cancer
Real-World Evidence (RWE) Study on Burden, Healthcare Resource Utilization, & Cost of Illness Among Patients Diagnosed With Myopia in Germany: Retrospective, Longitudinal, Observational Cohort Claims Data Study. Value in Health 2024, Volume 27, Issue 12, Supplement https://doi.org/10.1016/j.jval.2024.10.3734
Therapy areas: Ophthalmology
Indications: Myopia
Real-world psoriasis treatment patterns and disease burden in Germany, with a focus on biologics and apremilast: data from a German statutory health insurance database. Journal of Medical Economics, 28(1), 207–220. https://doi.org/10.1080/13696998.2025.2452054
Therapy areas: Dermatology
Indications: Psoriasis
Inzidenz und Folgekosten von intrakraniellen Blutungen bei Therapie mit oralen Faktor-Xa Inhibitoren in Deutschland. 24. Kongress der Deutschen Interdisziplinären Vereinigung für Intensiv- und Notfallmedizin e.V. (DIVI 24), 04 – 06.12. 2024, Hamburg. No DOI/URL available
Therapy areas: Neurology
Indications: Intracranial Haemorrhage
Costs and Complications of Respiratory Syncytial Virus and Acute Respiratory Infections in the Adult Population: Analysis of a German Claims Database. Pharmacoecon Open. 2025 Mar 19. https://doi.org/10.1007/s41669-025-00565-3
Therapy areas: Infectious Diseases
Indications: RSV
Economic burden of disease and mortality of intracranial haemorrhage under oral FXai: a German claims data analysis. Neurol. Res. Pract. 7, 21 (2025). https://doi.org/10.1186/s42466-025-00366-3
Therapy areas: Neurology
Indications: Intracranial Haemorrhage
Epidemiology and burden of mild/moderate versus high myopia in Germany: A claims data analysis. Journal: Acta Ophthalmologica. Published: 08 September. 2025. https://doi.org/10.1111/aos.17589 No DOI/URL available
Therapy areas: Ophthalmology
Indications: Myopia
Epidemiology of generalized pustular psoriasis in Germany: Analyzing factors influencing prevalence estimates from claims data. JDDG: Journal der Deutschen Dermatologischen Gesellschaft. https://doi.org/10.1111/ddg.15633
Therapy areas: Dermatology
Indications: Psoriasis
Understanding the Burden of Heart Failure: Insights from National Data and Healthcare Utilization Patterns in Heart Failure Patients in Germany – Room for Improvement. 91. DGK (Deutsche Gesellschaft für Kardiologie)-Jahrestagung, 23. – 26. April 2025, Mannheim. https://doi.org/10.1007/s00392-025-02625-4
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Heart Failure
Real-world clinical and economic outcomes of nonobstructive hypertrophic cardiomyopathy: a german claims data analysis. ESC (European Society of Cardiology) Heart Failure Congress organised by the Heart Failure Association of the ESC (HFA). 17 May - 20 May 2025, Belgrade. Published in: (2025), Abstract. Eur J Heart Fail, 27: 3-542. https://doi.org/10.1002/ejhf.3736
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Cardiomyopathy
Atlas-CKD – Aktuelle Epidemiologie und Gesundheitskennzahlen von CKD Patient:innen in Deutschland. 131. Kongress der Deutschen Gesellschaft für Innere Medizin (DGIM 2025), 03. – 06. Mai 2025, Wiesbaden. Published in: Abstracts zum 131. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.. Innere Medizin 66 (Suppl 1), 1–198 (2025). https://doi.org/10.1007/s00108-025-01898-1
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Chronic Kidney Disease
Optimierung der Versorgung von Patienten mit kardiorenalem Syndrom: Bedeutung der sektorenübergreifenden Therapie. 131. Kongress der Deutschen Gesellschaft für Innere Medizin (DGIM 2025), 03. – 06. Mai 2025, Wiesbaden. Published in: Abstracts zum 131. Kongress der Deutschen Gesellschaft für Innere Medizin e.V.. Innere Medizin 66 (Suppl 1), 1–198 (2025). https://doi.org/10.1007/s00108-025-01898-1
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Heart Failure
ATLAS-CKD – Aktuelle Epidemiologie und Gesundheitskennzahlen von CKD Patient:innen in Deutschland. Diabetes Kongress 2025 - DDG (Deutsche Diabetes Gesellschaft). 28. – 31. May 2025, Berlin. Published in: Diabetologie und Stoffwechsel, Neue Dimensionen der Diabetologie – Individuell. Interdisziplinär.Innovativ. Ausgabe S 01 · Volume 20 · Mai 2025. https://doi.org/10.1055/s-015-61776
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Chronic Kidney Disease
Unveiling gaps in heart failure management in Germany: a retrospective analysis of national data and healthcare utilisation patterns. European Society of Cardiology (ESC) Congress 2025, 29 August – 01 September 2025, Madrid. No DOI/URL available
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Heart Failure
Epidemiology and management of CKD with type 2 diabetes: insights from German claims data. 61st EASD Annual Meeting of the European Association for the Study of Diabetes, 15 - 19 September 2025, Wien. Published in: Diabetologia 68 (Suppl 1), 1–754 (2025). https://doi.org/10.1007/s00125-025-06497-1
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Chronic Kidney Disease
Treatment and associated outcomes of type 2 diabetes mellitus patients with a cardiovascular comorbidity and comparison with guideline recommendations: a German claims data analysis. Cardiovasc Diabetol 24, 364 (2025). https://doi.org/10.1186/s12933-025-02864-9
Therapy areas: Cardiovascular, Renal and Metabolism
Indications: Diabetes Type 2
Real-world treatment patterns and survival outcomes in patients with locally advanced squamous cell carcinoma of the head and neck in Germany using claims data. Front. Oncol. 15:1547311. https://doi.org/10.3389/fonc.2025.1547311
Therapy areas: Oncology/Hematology
Indications: Head and Neck Cancer
Sie sehen gerade einen Platzhalterinhalt von OpenStreetMap. Um auf den eigentlichen Inhalt zuzugreifen, klicken Sie auf die Schaltfläche unten. Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
Mehr InformationenSie sehen gerade einen Platzhalterinhalt von Google Maps. Um auf den eigentlichen Inhalt zuzugreifen, klicken Sie auf die Schaltfläche unten. Bitte beachten Sie, dass dabei Daten an Drittanbieter weitergegeben werden.
Mehr Informationen